S408 (Potassium Citrate Extended-Release 15 mEq (1620 mg))
Pill with imprint S408 is Yellow, Capsule-shape and has been identified as Potassium Citrate Extended-Release 15 mEq (1620 mg). It is supplied by Vensun Pharmaceuticals, Inc..
Potassium citrate is used in the treatment of nephrolithiasis; renal tubular acidosis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 15 mEq (1620 mg) is not a controlled substance under the Controlled Substances Act (CSA).
Images for S408
Potassium Citrate Extended-Release
- Imprint:
- S408
- Strength:
- 15 mEq (1620 mg)
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Urinary pH modifiers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Vensun Pharmaceuticals, Inc.
- Manufacturer:
- Strides Shasun Limited
- National Drug Code (NDC):
- 42543-0408
More about potassium citrate
- Potassium citrate Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: urinary pH modifiers
Consumer resources
Other brands: Urocit-K
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
